Key result
Vascular risk factor control remains persistently low over two decades among US stroke survivors.
Why the study?
Management of modifiable risk factors is key in preventing recurrent stroke, prompting an investigation into trends in vascular risk factor control among US adults with stroke.
Does adherence to guideline-recommended vascular risk factor control targets improve over time among US adults with prior stroke?
Cross-Sectional (n=2,778)
Does adherence to guideline-recommended vascular risk factor control targets improve over time among US adults with prior stroke?
Absolute Event Rate: 2% vs 2.6%
p-value: p=0.18
Adherence to comprehensive vascular risk factor targets among US stroke survivors has remained stagnant and poor over two decades, emphasizing the need for targeted implementation strategies in secondary stroke prevention.
Stagnant low comprehensive control in stroke survivors cautions against assuming progress in secondary prevention; leaves open the effectiveness of targeted implementation strategies.
Background Management of modifiable risk factors is key in the prevention of recurrent stroke. We investigated trends in vascular risk factors (hyperglycemia, hyperlipidemia, hypertension, and smoking) control among US adults with stroke. Methods We performed analyses of data from 1999 through 2023 National Health and Nutrition Examination Surveys participants with self‐reported stroke. Meeting guideline‐recommended targets for risk factor control was defined as hemoglobin A 1c <6.5% without diabetes or hemoglobin A 1c <7.0% with diabetes, low‐density lipoprotein cholesterol <70 mg/dL, blood pressure <130/80 mm Hg, and nonsmoking. Age‐standardized mean hemoglobin A 1c , low‐density lipoprotein, and blood pressure and prevalence of meeting each recommended target were calculated for each epoch (1999 through 2002, 2003 through 2006, 2007 through 2010, 2011 through 2014, 2015 through 2020, and 2021 through 2023). Results Mean hemoglobin A 1c increased from 5.7% (95% CI, 5.5–5.9) in 1999 through 2002 to 6.0% (95% CI, 5.7–6.3) in 2021 through 2023 ( P ‐trend=0.04) and LDL decreased from 125.9 mg/dL (95% CI, 119.4–132.4) in 1999 through 2002 to 115.6 mg/dL (95% CI, 107.8–123.5) in 2021 through 2023 ( P ‐trend<0.001), whereas blood pressure was largely stable. The prevalence of meeting glycemia guidelines decreased from 90.7% (95% CI, 85.9%–95.6%) in 1999 through 2002 to 83.9% (95% CI, 70.2%–97.5%) in 2021–2023 ( P ‐trend=0.03), whereas the prevalence of meeting lipid guidelines increased from 1999 through 2002 (5.1% [95% CI, 0%–11.0%]) to 2021 through 2023 (13.6% [95% CI, 6.9%–20.4%; P ‐trend=0.002). The prevalence of meeting smoking and blood pressure guidelines was stable. Fewer than 10% of individuals met guidelines for all 4 risk factors over the study. Conclusions In this nationally representative sample of US adults with stroke, <10% met guideline recommendations for all risk factors with an overall stable trend. These results suggest that efforts aimed at glycemia, blood pressure, and lipid control and smoking cessation could be improved to reduce the burden of recurrent stroke.
No takes yet. Share an insight, caveat, or question.
Andres et al. (2026) conducted a cross-sectional in Prior stroke (n=2,778). Time period (2021-2023 vs 1999-2002) vs. 1999-2002 survey epoch was evaluated on Meeting guideline recommendations for all 4 risk factors (glycemia, lipids, blood pressure, and smoking) (p=0.18). Among US adults with prior stroke, the proportion meeting guideline recommendations for all 4 major modifiable vascular risk factors remained persistently low and stable over time, at 2.6% in 1999-2002 and 2.0% in 2021-2023.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: